コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 nd characterized the enzyme CpdA, a putative cAMP phosphodiesterase.
2 resence and absence of IBMX, an inhibitor of cAMP phosphodiesterase.
3 mice of partial inhibition of a hippocampal cAMP phosphodiesterase.
4 the active site of PDE3A as well as in other cAMP phosphodiesterases.
5 actamase domain, a superfamily that includes cAMP phosphodiesterases.
6 ase-4 (PDE4) inhibitor rolipram, but not the cAMP phosphodiesterase-3 (PDE3) inhibitor cilostamide, c
8 kolin together with the specific cyclic AMP (cAMP) phosphodiesterase-4 (PDE4) inhibitor rolipram, but
9 ded by protein kinase A-RII, beta-arrestin2, cAMP phosphodiesterase-4D3, and cAMP phosphodiesterase-4
11 We demonstrate that CpdA possesses 3',5'-cAMP phosphodiesterase activity in vitro and that it uti
12 o alanine or asparagine suppressed the 2',3'-cAMP phosphodiesterase activity of Rv0805 without advers
13 Rp-Br-cAMP[S]) and when the cGMP-inhibitable cAMP phosphodiesterase activity was inhibited by pretrea
15 m of of the calmodulin-dependent activity of cAMP phosphodiesterase and for binding affinity to rat u
17 ing neurons in response to NMDA receptor and cAMP phosphodiesterase antagonists and occurred graduall
18 re mediated by cAMP, as injection of cAMP or cAMP phosphodiesterase disrupts wave propagation and res
22 reas reducing cAMP pulse size with exogenous cAMP phosphodiesterase during stream formation causes ce
23 terases, and in particular the high-affinity cAMP phosphodiesterase encoded by PDE2, have real potent
26 ositively coupled to adenylyl cyclase, and a cAMP phosphodiesterase inhibitor ameliorated the physiol
27 s were transient, but in the presence of the cAMP phosphodiesterase inhibitor isobutylmethylxanthine
28 ing that CGRP gene transfer alone and with a cAMP phosphodiesterase inhibitor may be useful for the t
29 hanged and decreases in PAP in response to a cAMP phosphodiesterase inhibitor were enhanced by AdRSVC
30 entiation inducers methylisobutylxanthine (a cAMP phosphodiesterase inhibitor) or Forskolin, both of
31 pocytes induced by methylisobutylxanthine (a cAMP phosphodiesterase inhibitor), dexamethasone, and in
32 ling pathway by rolipram, a selective Type 4 cAMP phosphodiesterase inhibitor, reverses MK-801-induce
33 chronic (12-15 day) exposure to the type IV cAMP phosphodiesterase inhibitor, Ro20-1724, were examin
36 rtant regulator of external cAMP levels, the cAMP phosphodiesterase inhibitor, we can explain the nat
40 Theophylline, a competitive inhibitor of cAMP phosphodiesterase, inhibits the maturation of oocyt
43 s strongly reduces the function of the Dunce cAMP phosphodiesterase PDE-4 by disrupting a conserved a
45 responsible for this change in cAMP levels, cAMP phosphodiesterase (PDE) and adenylyl cyclase activi
46 ions affecting the Schizosaccharomyces pombe cAMP phosphodiesterase (PDE) gene cgs2+ were identified
47 we have tested the hypothesis that specific cAMP phosphodiesterase (PDE) isoforms of the PDE4D famil
49 ease in cAMP, brought about by the action of cAMP phosphodiesterase (PDE), is thought to initiate ger
50 ne whether a cyclic adenosine monophosphate (cAMP) phosphodiesterase (PDE), PDE4, is expressed in hum
51 mulates filamentation in strains lacking the cAMP phosphodiesterase PDE2, even in the absence of nitr
52 ared the roles of the high- and low-affinity cAMP phosphodiesterases, Pde2p and Pde1p in stress, adhe
53 osine 3',5'-cyclic monophosphate inactivates cAMP phosphodiesterase (PDE3A); however, millimolar conc
60 sses of adenosine 3'5' cyclic monophosphate (cAMP) phosphodiesterases (PDEs), induces apoptosis in ch
61 sation evolved, we studied the origin of the cAMP phosphodiesterase PdsA and its inhibitor PdiA, whic
62 yl M anion-exchange chromatography, showed a cAMP phosphodiesterase peak that was minimally sensitivi
63 tyl-1-methylxanthine (IBMX), an inhibitor of cAMP phosphodiesterase, potentiated PGE2-induced suppres
65 s in which the gene encoding the cytoplasmic cAMP phosphodiesterase RegA is inactivated form small ag
66 eceptor DhkA, it reduces the activity of the cAMP phosphodiesterase RegA such that cAMP levels can in
68 ressor studies indicate that the cyclic AMP (cAMP) phosphodiesterase RegA and the cAMP-dependent prot
70 the effects of phosphodiesterase 4 (PDE4), a cAMP phosphodiesterase that is phosphorylated and inhibi
71 on and DON production, and Pde2 is the major cAMP phosphodiesterase to negatively regulate DON biosyn
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。